Richard J. Tajak

Richard J. Tajak joined Nant Holdings, Inc. in July 2011 as Chief Financial Officer. Mr. Tajak has over 25 years of progressive financial experience, principally within the pharmaceutical industry. He most recently served for three years as Chief Financial Officer for APP Pharmaceuticals, Inc., a $1 billion generic pharmaceutical company. Prior to that, he was Senior Vice President, Finance for the $1.5 billion North American division of Astellas Pharmaceuticals, Inc. His earlier career was at Fujisawa Healthcare/USA and Lyphomed, Inc., where he had increasing levels of responsibility in the areas of accounting, finance, SEC reporting, audit, tax and corporate operations. Mr. Tajak holds a Bachelors degree in Finance and an MBA from the University of Notre Dame, and is a Certified Public Accountant.